CLINICAL TRIALS PROFILE FOR LOCOID
✉ Email this page to a colleague
All Clinical Trials for LOCOID
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00693693 ↗ | Adherence to Topical Hydrocortisone 17-butyrate 0.1% (Locoid®) Using Different Vehicles in Adults With Atopic Dermatitis | Completed | Wake Forest University | Phase 4 | 2006-11-01 | The purpose of this research study is to better understand adherence to Locoid when people use it to treat atopic dermatitis. |
| NCT00871208 ↗ | Trial of Treatment of Atopic Dermatitis With Concurrent Altabax® and Topical Low-Potency Corticosteroids Versus Low-Potency Corticosteroid Mono-therapy | Withdrawn | GlaxoSmithKline | Phase 4 | 2009-05-01 | This study is designed to determine whether the addition of topical Altabax (R) to a treatment regimen of topical corticosteroid therapy speeds clearance of atopic dermatitis and improves quality of life. |
| NCT00871208 ↗ | Trial of Treatment of Atopic Dermatitis With Concurrent Altabax® and Topical Low-Potency Corticosteroids Versus Low-Potency Corticosteroid Mono-therapy | Withdrawn | St. Luke's-Roosevelt Hospital Center | Phase 4 | 2009-05-01 | This study is designed to determine whether the addition of topical Altabax (R) to a treatment regimen of topical corticosteroid therapy speeds clearance of atopic dermatitis and improves quality of life. |
| NCT02153762 ↗ | Treatment of Atopic Dermatitis With Different Orders of Application of Locoid Lotion and Hylatopic Plus Cream | Completed | Icahn School of Medicine at Mount Sinai | N/A | 2013-04-01 | The purpose of this study is to evaluate the safety and tolerability, as well as effectiveness, with regards to the order of application for Locoid Lipocream and Hylatopic Plus cream in patients with atopic dermatitis (AD), which is a type of skin rash.Topical skin barrier repair therapies (BRT) that are plain moisturizing creams/lotions with added lipids (fats/oils), such as Hylatopic Plus cream, have emerged as an effective addition to the the treatment of atopic dermatitis. BRTs are often used along with topical steroids (medicated creams), such as Locoid lotion, on skin with AD, and as a monotherapy (single treatment) on both non-diseased and diseased skin. Since BRTs help to restore components of skin that are absent in skin with AD, it is believed that long-term BRT use may reduce further development of further AD. This is an open-label, single site study. |
| NCT02973776 ↗ | Vasoconstriction Trial With LEO 90100 Aerosol Foam | Completed | LEO Pharma | Phase 1 | 2016-12-01 | Vasoconstriction study with LEO 90100 |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for LOCOID
Condition Name
Clinical Trial Locations for LOCOID
Trials by Country
Clinical Trial Progress for LOCOID
Clinical Trial Phase
Clinical Trial Sponsors for LOCOID
Sponsor Name
